Last reviewed · How we verify
ZH9PA and ZH9
ZH9PA and ZH9 is a Biologic drug developed by Prokarium Ltd. It is currently in Phase 1 development. Also known as: Entervax.
At a glance
| Generic name | ZH9PA and ZH9 |
|---|---|
| Also known as | Entervax |
| Sponsor | Prokarium Ltd |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Vomiting
- Diarrhoea
- Abdominal pain
- Oropharyngeal pain
- Dyspepsia
- Influenza like illness
- Taste disorder
- Headache
- Nasopharyngitis
- Nausea
- Sinusitis
- Arthralgia
Key clinical trials
- Study to Evaluate the Safety, Tolerability and Immunogenicity of a Potential Enteric Fever Vaccine (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ZH9PA and ZH9 CI brief — competitive landscape report
- ZH9PA and ZH9 updates RSS · CI watch RSS
- Prokarium Ltd portfolio CI
Frequently asked questions about ZH9PA and ZH9
What is ZH9PA and ZH9?
ZH9PA and ZH9 is a Biologic drug developed by Prokarium Ltd.
Who makes ZH9PA and ZH9?
ZH9PA and ZH9 is developed by Prokarium Ltd (see full Prokarium Ltd pipeline at /company/prokarium-ltd).
Is ZH9PA and ZH9 also known as anything else?
ZH9PA and ZH9 is also known as Entervax.
What development phase is ZH9PA and ZH9 in?
ZH9PA and ZH9 is in Phase 1.
What are the side effects of ZH9PA and ZH9?
Common side effects of ZH9PA and ZH9 include Vomiting, Diarrhoea, Abdominal pain, Oropharyngeal pain, Dyspepsia, Influenza like illness.
Related
- Manufacturer: Prokarium Ltd — full pipeline
- Also known as: Entervax
- Compare: ZH9PA and ZH9 vs similar drugs
- Pricing: ZH9PA and ZH9 cost, discount & access